Keynote Presentations

Human Genome: Advances in Extracting Useful Data
Yoshihide Hayashizaki, M.D., Ph.D., Director, Omics Science Center, RIKEN, Japan

Eisai Global R&D Strategy
Kentaro Yoshimatsu, Ph.D., Senior Vice President, Research & Development, Eisai Co., Ltd., Japan

Special FDA Presentation

FDA's Strategy for Predictive Toxicology
Donna L. Mendrick, Ph.D., Director, Division of Systems Toxicology, NCTR, U.S. Food and Drug Administration, USA

Benchmark Your R&D Efforts, Find New Markets & Develop Your Drug Hunting Skills

• Improve compound design, optimization and selection using cell-based, biomarker, translational and other technologies
• Learn how to build an antibody and biologics franchise: Hear scientific strategies from worldwide experts
• Explore global progress on RNAi therapeutic development and meet seven top RNAi companies
• Hear how your competitors are expanding their R&D operations outside of Japan and globally
• Connect with potential partners from over 25 North American and European companies

New This Year

• The Antibody Discovery & Protein Science Summit
• Specialized Tutorial on Immunogenicity Prediction
• Two Concurrent Sessions Featuring 50+ Speakers

» View the Entire Conference Agenda
» View these Individual Agendas:

• The Antibody Discovery and Protein Science Summit (PDF)
• Tutorial: Immunogenicity Prediction of Antibody and Protein Therapeutics (PDF)
• RNAi as a Therapeutic Modality (PDF)